Dexin China’s $190 Million Initial Public Offering


O’Melveny recently represented Dexin China Holdings Company Limited in its US$190 million initial public offering on the Main Board of the Hong Kong Stock Exchange (2019.HK).

CCB International Capital Limited is the sole sponsor and the sole global coordinator of the IPO. CCB International Capital Limited, BOCOM International Securities Limited and China Everbright Securities (HK) Limited are the joint bookrunners of the IPO.

Dexin China Holdings Company Limited is a leading comprehensive property developer based in Zhejiang Province, China, focusing primarily on the development of residential properties and the development, operation and management of commercial and mixed-use properties.

The O’Melveny team was led by partners Edwin Kwok (Picture) and Ke Geng, with support from counsels Lillian Cheung and Huang Ke, associates Wendy Kan and Yuki Tsang, legal consultant Qiyan Wang, and trainee solicitors Hilda Leung and Darryl Wan.

Involved fees earner: Lillian Cheung – O’Melveny & Myers LLP; Ke Geng – O’Melveny & Myers LLP; Ke Huang – O’Melveny & Myers LLP; Wendy Kan – O’Melveny & Myers LLP; Edwin Kwok – O’Melveny & Myers LLP;

Law Firms: O’Melveny & Myers LLP;

Clients: Dexin China Holdings Co Ltd;